🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Experimental Drug Gaining Popularity Online

The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed fat-burning effects. Viewers are urged to contact these profiles directly for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and assertions of next-day British shipping. Sellers market the drug there before redirecting customers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Express Worries

Nevertheless, physicians and chemists have cautions that the sale of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals administering products of unknown origin.

Some experts said the demand for retatrutide could be connected to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach pharmaceutical, advertising, and customer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Reaction and Content Removal

Based on TikTok, the platform has taken down violative content and prohibited associated hashtags and query recommendations. The company stated it was dedicated to maintaining the service safe and investing in strengthening enforcement strategies.

Digital Trading Activities

Investigations also discovered groups with up to 9,000 members selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, populated with photos of weight loss, positive reviews and detailed guides for preparing or injecting at residence.

After moments of entering one community, a vendor posted contact information, where most transactions occur. The seller sent an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or past usage.

Item Information and Costs

Inside these communities, posts show black plastic packages with postal service stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20mg. When asked how much time a pen should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram said it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering substances they cannot confirm. Although the science behind retatrutide is valid, these digital versions may not contain what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit injections are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has previously encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to possibly serious health risks”.